Thomas Keller

Investment Partner

Langdon Wu

Managing Director

Taoqi Huangfu Ph.D

Partner and Managing Director

Jack Zheng Yin Ph.D

Founder and Partner

1 past transactions

Axcynsis Therapeutics

Seed Round in 2022
Tetris Therapeutics is a platform-based biotechnology company focusing on the development of antibody drug conjugate (ADC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of ADC candidates with the potential to address unmet medical needs for new treatment options.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.